Filing Details

Accession Number:
0001104659-24-001490
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-01-04 20:09:17
Reporting Period:
2023-11-15
Accepted Time:
2024-01-04 20:09:17
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1377121 Protagonist Therapeutics Inc PTGX Pharmaceutical Preparations (2834) 980505495
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1398940 Md Arturo Molina C/O Protagonist Therapeutics, Inc.
7707 Gateway Blvd., Suite 140
Newark CA 94560-1160
Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2023-11-15 1,848 $16.24 22,527 No 4 S Direct
Common Stock Acquisiton 2024-01-02 26,250 $0.00 48,777 No 4 A Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 A Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Acquisiton 2024-01-02 97,500 $0.00 97,500 $23.42
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
97,500 2034-01-02 No 4 A Direct
Footnotes
  1. Sale of shares to cover tax withholding obligation incurred upon settlement of restricted stock units.
  2. Represents grant of restricted stock units payable solely in common stock that will vest in three equal annual installments on January 15, 2025, 2026 and 2027, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date.
  3. The stock option vests in 48 equal monthly installments following January 2, 2024, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date.